China AI: Bernstein sees chipmakers benefiting from Nvidia scrutiny
Investing.com -- Danish hearing aid maker Demant on Tuesday reported first-half EBIT of 1.85 billion Danish crowns ($269 million) on flat organic sales and lowered its 2025 forecast, citing softer global demand and weaker sales to a large U.S. retailer.
The company now expects full-year organic growth of 1-3%, down from 1-5%, and EBIT of 3.9-4.3 billion crowns, compared with 4.1-4.5 billion previously.
Demant trimmed its estimate for global hearing aid market growth this year to 1-3% from 2-4%, pointing to macroeconomic uncertainty and intense competition.
"The first half of the year brought headwinds to the Group in terms of macroeconomic uncertainties, driving soft market conditions and intense competition, and to reflect continued uncertainties in the second half-year, we are adjusting our 2025 outlook,” says CEO Søren Nielsen.
“While near-term growth will be more modest than previously anticipated, we have seen good momentum and market share gains in units in Hearing Aids in the second quarter”